EUVIMED · CrossrefZeitschrift
Molecular Diversity
ISSN 1573-501X · Springer Science and Business Media LLC
Neueste Artikel
Correction: Addressing the selectivity challenge in matrix metalloproteinases: fragment-based design of MMP-9 inhibitors targeting the S1′ pocket
In silico directed evolution of humanized peptide transporters via computational epistatic rescue
Evaluation of toll-like receptor inhibition by novel thymoquinone analogues as potential remedy for diabetic nephropathy
Discovery of a new SARS-CoV-2 Mpro inhibitor from a natural product and natural product-like compound database using in silico and in vitro studies
Exploring the molecular mechanism of benzo[a]pyrene affecting prostate cancer based on network toxicology and external validation
Discovery of potent and selective MAO-B inhibitors from a morpholine-substituted chalcone library for neurodegenerative disorders
Structure-based drug repurposing and in vitro evaluation of VAV2-associated candidates for suppression of macrophage foam-cell formation in atherosclerosis
Correction: Identification and validation of natural dengue virus NS1 inhibitors with promising antiviral potential
HD-SKRG: a hierarchical dual-view and structure-knowledge relation graph enhancement network for few-shot molecular property prediction
Artificial intelligence-guided discovery of fungal ergosterol derivatives as selective LXRβ agonists targeting the cholesterol dependency of glioblastoma
Lipase ITB 2.1: a structure- and function-validated model for anti-obesity drug screening
Computational discovery of novel human rhinovirus 3 C protease inhibitors: molecular docking, dynamic simulations, free energy landscape, MMPBSA and ADMET analysis
Molecular-networking-based characterization of cytotoxic metabolites produced by the cyanobacterium Nostoc edaphicum CCNP1411
Hot spot-driven discovery of β-catenin/Tcf4 interaction inhibitors via virtual drug repurposing study and experimental validation in colorectal cancer cells
Addressing the selectivity challenge in matrix metalloproteinases: fragment-based design of MMP-9 inhibitors targeting the S1′ pocket
Electrochemical synthesis of antioxidant trideuteromethylthiolated enaminones through three-component cascade reactions
Recent advances of dual PROTACs for potential therapeutic applications
A dynamic fusion diffusion model for molecular generation
PFOS exposure is linked to immune-metabolic disruption in MASLD: integrated population, computational, and experimental evidence
FlavorGPN: a graph neural network for multi-label molecular flavor prediction
Integrating machine learning and deep learning with multiple molecular fingerprints for topoisomerase I inhibitor screening and lead identification
De novo generation and computational screening of dual-targeting short peptide inhibitors against PBP2b and PBP2x in drug-resistant Streptococcus Pneumoniae
Computational discovery and dynamic profiling of dual acetylcholinesterase and monoacylglycerol lipase inhibitors for Alzheimer’s disease
Free energy perturbation and machine learning-assisted identification of novel molecules for the Mycobacterium tuberculosis KasA protein: a fragment-based drug design approach
Multi-omics, machine learning, and molecular simulation identify CD44 as a candidate target in endocrine-disrupting chemical–associated thyroid cancer progression
DSC-bsite: a dynamic–static collaborative multimodal graph learning method for protein–small molecule binding site prediction
Discovery of aloe-emodin as an antidepressant agent by targeting RANBP9
Harnessing machine learning, docking and molecular dynamics for the virtual screening of compounds as CDK4/6 dual inhibitors
Interpretable QSAR modelling for PPAR-γ agonist prediction by integrating a stacking strategy, docking, and MD simulations
Identification of novel serotonin transporter (SERT) inhibitors via large-scale machine learning-based virtual screening and molecular dynamics simulations
EUVIMED